Letters and Comments

FDA Informed Consent Comments Submitted

April 26, 2024
Letters and Comments

Blood Center LDTs Exemption Urged to Congress

April 5, 2024
Letters and Comments

FDA 506J Guidance Comments

March 1, 2024
Letters and Comments

FDA Draft Report Comments & Plan on Best Practices Guidance

February 23, 2024
Letters and Comments

Blood Supply Sustainability Joint Comments to ACBTSA

January 5, 2024
Letters and Comments

Laboratory Developed Tests Comments Submitted

December 8, 2023
Letters and Comments

PMI Proposed Rule for Blood Comments

December 4, 2023
Letters and Comments

Comments Regarding Surge Capacity Recommendations from HHS ACBTSA

November 17, 2023
Letters and Comments

Hospital OPPS Blood Reimbursement Reform Requested

September 11, 2023